Medicine

Medicines produced by the aggressor country and its satellite, belarus, are under sanctions and banned for supply to Ukraine. Are patients going to feel the lack of "aggressive" medicines and will pharmaceutical companies benefit?

How market players survive, interact with one another and overcome difficulties in the new situation

One of the largest resource suppliers for the agro-industrial complex on the synergy of synthetic and biological products, war changes in the industry, and the harvest forecasts.

How public and municipal hospitals work after 24 February and whether all services are available for patients

And ways to encourage employees to build a progressive future

And why pharmacists spare no money on innovation

Ukrainian pharmaceutical market will grow and stay popular among the investors in the next years. The generic drugs producers will win the most

And why is it unique for Ukraine.

What factors can attract foreign capital into the industry